期刊文献+

辅助生殖技术供卵法规合理性的伦理学思考 被引量:5

Ethical Reflection on Legitimacy of Regulation on Oocyte Donation in Assisted Reproductive Technology
下载PDF
导出
摘要 供卵技术主要用于解决不孕不育问题,促进辅助生殖技术的发展,但同时引发一系列伦理法律问题。根据我国供卵的现状及已颁布的法律法规和章程等对供卵技术实施的风险、卵子来源、供/受者条件、增加近亲婚配危险、子代法律地位以及知情权与隐私权的冲突等伦理法律问题进行论述和分析,并认为在供卵技术实施过程中,既要做到供/受卵双方的知情同意,又要严防该技术的商业化。因此,我国应加强供卵技术的伦理规约与法律应对,使这类妇女实现生育愿望的同时,又完全遵循合理的伦理法律原则,保证供卵技术合理开展。 Oocyte donation is mainly to solve the problem of infertility in women and promote the development of assisted reproductive technology,which also raises a number of ethical issues.This article analyzed the health risks of oocyte donation,the source of oocyte,the condition of donation/recipient,the increase of the risks of consanguineous marriage,the legal status of children,and the conflicts between the right to know and the right of privacy based on the present situation of oocyte donation and its laws in China.It is believed that both the informed consent of donor/recipient and the commercialization of the technology must be strictly prevented in the process of oocyte donation.Therefore,we should strengthen the construction of ethical regulation of oocyte donation technology and laws,and make these people realize their reproductive desire following ethical and legal principles so as to ensure the sound development of oocyte donation.
作者 谢宝国 卢伟英 XIE Bao-guo;LU Wei-ying(Reproductive Medical Center,The First Affiliated Hospital of Hainan Medical Hospital, Haikou 570102, China)
出处 《医学与哲学(A)》 2018年第5期26-27,共2页 Medicine & Philosophy:Humanistic & Social Medicine Edition
基金 2016年国家自然科学基金项目(81560244) 2017年海南省重大科技计划项目(2017007)
关键词 辅助生殖技术 供卵 伦理 assisted reproductive technology, oocyte donation, ethics
  • 相关文献

参考文献1

二级参考文献38

  • 1周灿权,钟依平.对超排卵反应不良患者的应对策略[J].实用妇产科杂志,2005,21(8):463-466. 被引量:14
  • 2黄洁,刘嘉茵.35岁以上不孕妇女卵巢反应及临床妊娠结局的预测[J].药物生物技术,2006,13(6):460-463. 被引量:6
  • 3Mohamed MA, Sbraeia M, Paechiarotti A, et al. Urinary follicle-stimulating hormone (FSH) is more effective than recombinant FSH in older women in a controlled randomized study[J]. Fertil Steril, 2006,85 : 1398-1403.
  • 4Swanton A,Child T. Reproduction and ovarian ageing[J]. J Br Menopause Soc, 2005,11 : 126-131.
  • 5Oudendijk JF, Yarde F, Eijkemans MJ, et al. The poor responder in IVF:is the prognosis always poor? A systematic review[J]: Hum Reprod Update, 2012,18 : 1-11.
  • 6Roudebush WE, Kivens WJ, Mattke JM. Biomarkers of ovarian reserve[J]. Biomark Insights, 2008,3 : 259-268.
  • 7Sharara FI,McClamroc HD. Use of microdose GnRH agonist protocol in women with low ovarian volumes undergoing IVF [J]. Hum Reprod, 2001,16 : 500-503.
  • 8Kupesie S, Kurjak A, Sjelos D, et al. Three-dimensional ultrasonographie ovarian measurements and in vitro fertilzation outcome are related to age [J]. Ferti[ Steril, 2003,79 : 190-197.
  • 9Bancsi LF, Brroekmans FJ, Eij kemans M J, et al. Predictors of poor ovarian response in in vitro fertilization: a prospective study comparing basal markers of ovarian reserve[J]. Fertil Steril,2002.77:328-336.
  • 10Bassil S, Wyns C, Toussaint-Demylle D, et al. The relationship between ovarian vascularity and the duration of stimulation in in-vitro fertilization[J]. Hum Reprod, 1997, 12:1240-1245.

同被引文献48

引证文献5

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部